Profile data is unavailable for this security.
About the company
Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.
- Revenue in AUD (TTM)3.74m
- Net income in AUD-5.63m
- Incorporated2000
- Employees8.00
- LocationInvion Ltd100 Albert Road, South MelbourneMELBOURNE 3205AustraliaAUS
- Phone+61 39692-7222
- Fax+61 73295-0599
- Websitehttps://inviongroup.com/